Masimo Change in Assets/Liabilities 2010-2025 | MASI
Masimo annual/quarterly change in assets/liabilities history and growth rate from 2010 to 2025. Change in assets/liabilities can be defined as represents any other changes in assets/liabilities
- Masimo change in assets/liabilities for the quarter ending March 31, 2025 was $7M, a 7.25% increase year-over-year.
- Masimo change in assets/liabilities for the twelve months ending March 31, 2025 was $-0.011B, a 89.3% decline year-over-year.
- Masimo annual change in assets/liabilities for 2024 was $0.013B, a 268.42% decline from 2023.
- Masimo annual change in assets/liabilities for 2023 was $-0.008B, a 20.63% increase from 2022.
- Masimo annual change in assets/liabilities for 2022 was $-0.006B, a 32.98% decline from 2021.
| Masimo Annual Change in Assets/Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $13 |
| 2023 | $-8 |
| 2022 | $-6 |
| 2021 | $-9 |
| 2020 | $-31 |
| 2019 | $-7 |
| 2018 | $-16 |
| 2017 | $-16 |
| 2016 | $8 |
| 2015 | $-10 |
| 2014 | $-5 |
| 2013 | $-11 |
| 2012 | $-1 |
| 2011 | $-2 |
| 2010 | $-19 |
| 2009 | $-7 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.359B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.656B | 22.34 |
| Intuitive Surgical (ISRG) | United States | $172.162B | 71.36 |
| IDEXX Laboratories (IDXX) | United States | $52.070B | 54.19 |
| Edwards Lifesciences (EW) | United States | $45.946B | 30.45 |
| Alcon (ALC) | Switzerland | $43.262B | 29.24 |
| IQVIA Holdings (IQV) | United States | $32.485B | 18.36 |
| DexCom (DXCM) | United States | $31.745B | 47.62 |
| Mettler-Toledo (MTD) | United States | $27.033B | 32.09 |
| STERIS (STE) | Ireland | $24.185B | 25.74 |
| Waters (WAT) | United States | $17.354B | 23.84 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.707B | 0.00 |
| Hologic (HOLX) | United States | $15.082B | 16.34 |
| Penumbra (PEN) | United States | $9.868B | 72.09 |
| Sysmex ADR (SSMXY) | Japan | $8.529B | 27.10 |
| Globus Medical (GMED) | United States | $8.200B | 18.87 |
| Teleflex (TFX) | United States | $5.333B | 8.61 |
| Glaukos (GKOS) | United States | $5.153B | 0.00 |
| TransMedics (TMDX) | United States | $4.348B | 66.09 |
| Integer Holdings (ITGR) | United States | $3.741B | 18.67 |
| LivaNova (LIVN) | United Kingdom | $2.933B | 16.79 |
| Veracyte (VCYT) | United States | $2.377B | 32.85 |
| Alphatec Holdings (ATEC) | United States | $2.323B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.314B | 0.00 |
| Artivion (AORT) | United States | $2.020B | 101.93 |
| Nihon Kohden (NHNKY) | Japan | $1.911B | 22.82 |
| Elekta AB (EKTAY) | Sweden | $1.899B | 17.07 |
| Integra LifeSciences Holdings (IART) | United States | $1.106B | 6.33 |
| OPKO Health (OPK) | United States | $1.087B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.087B | 0.00 |
| IRadimed (IRMD) | United States | $0.895B | 43.44 |
| Beta Bionics (BBNX) | United States | $0.741B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.731B | 0.00 |
| AxoGen (AXGN) | United States | $0.687B | 0.00 |
| SiBone (SIBN) | United States | $0.667B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.558B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.520B | 9.18 |
| Semler Scientific (SMLR) | United States | $0.501B | 4.02 |
| OrthoPediatrics (KIDS) | United States | $0.481B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.435B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.393B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.379B | 9.63 |
| Delcath Systems (DCTH) | United States | $0.362B | 86.33 |
| AngioDynamics (ANGO) | United States | $0.356B | 0.00 |
| RxSight (RXST) | United States | $0.345B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.328B | 0.00 |
| NeuroPace (NPCE) | United States | $0.283B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.278B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.277B | 19.09 |
| 908 Devices (MASS) | United States | $0.238B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.227B | 0.00 |
| Neuronetics (STIM) | United States | $0.221B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.220B | 0.00 |
| Inogen (INGN) | United States | $0.202B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.190B | 0.00 |
| CVRx (CVRX) | United States | $0.184B | 0.00 |
| Accuray (ARAY) | United States | $0.158B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.156B | 0.00 |
| LENSAR (LNSR) | United States | $0.151B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.141B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.115B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.111B | 0.00 |
| Hyperfine (HYPR) | United States | $0.108B | 0.00 |
| InspireMD (NSPR) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.100B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.095B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.081B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.058B | 0.00 |
| Positron (POSC) | United States | $0.057B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.18 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.041B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.27 |